Literature DB >> 16803965

Free radical theory of aging: an update: increasing the functional life span.

Denham Harman1.   

Abstract

Aging is the progressive accumulation of diverse, deleterious changes with time that increase the chance of disease and death. The basic chemical process underlying aging was first advanced by the free radical theory of aging (FRTA) in 1954: the reaction of active free radicals, normally produced in the organisms, with cellular constituents initiates the changes associated with aging. The involvement of free radicals in aging is related to their key role in the origin and evolution of life. Aging changes are commonly attributed to development, genetic defects, the environment, disease, and an inborn aging process (IAP). The latter produces aging changes at an exponentially increasing rate with age, becoming the major risk factor for disease and death for humans after the age of 28 years in the developed countries. In them the IAP limits human average life expectancy at birth (ALE-B)--a rough measure of the healthy life span--to about 85 years; few reach 100 years and only one is known to have lived to 122 years. In these countries, improvements in living conditions (ILC) have gradually raised ALE-Bs to 76-79 years, 6-9 years less than the limit imposed by aging, with no change in the maximum life span (MLS). The extensive studies based on the FRTA hold promise that ALE-B and the MLS can be extended, the ALE-B possibly by a few years, and the MLS somewhat less.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16803965     DOI: 10.1196/annals.1354.003

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  144 in total

1.  Epigallocatechin-3-Gallate Protects Erythrocyte Ca(2+)-ATPase and Na(+)/K(+)-ATPase Against Oxidative Induced Damage During Aging in Humans.

Authors:  Prabhanshu Kumar; Pawan Kumar Maurya
Journal:  Adv Pharm Bull       Date:  2014-08-25

2.  Mutational bias plays an important role in shaping longevity-related amino acid content in mammalian mtDNA-encoded proteins.

Authors:  Juan Carlos Aledo; Héctor Valverde; João Pedro de Magalhães
Journal:  J Mol Evol       Date:  2012-06-30       Impact factor: 2.395

3.  Age- and gender-specific changes of hypocretin immunopositive neurons in C57Bl/6 mice.

Authors:  Sara E Brownell; Bruno Conti
Journal:  Neurosci Lett       Date:  2010-02-01       Impact factor: 3.046

4.  Dietary antioxidants and forced expiratory volume in 1 s decline: the Health, Aging and Body Composition study.

Authors:  A R Bentley; S B Kritchevsky; T B Harris; P Holvoet; R L Jensen; A B Newman; J S Lee; S Yende; D Bauer; P A Cassano
Journal:  Eur Respir J       Date:  2011-10-17       Impact factor: 16.671

Review 5.  The clinical implications of ageing for rational drug therapy.

Authors:  Shaojun Shi; Klaus Mörike; Ulrich Klotz
Journal:  Eur J Clin Pharmacol       Date:  2008-01-05       Impact factor: 2.953

6.  Longevity genomics across species.

Authors:  Matt Kaeberlein
Journal:  Curr Genomics       Date:  2007-04       Impact factor: 2.236

Review 7.  Mitochondrial pathways in human health and aging.

Authors:  Rebecca Bornstein; Brenda Gonzalez; Simon C Johnson
Journal:  Mitochondrion       Date:  2020-07-30       Impact factor: 4.160

8.  Melatonin and tumeric ameliorate aging-induced changes: implication of immunoglobulins, cytokines, DJ-1/NRF2 and apoptosis regulation.

Authors:  Ismail Ahmed Ismail; Hanan A El-Bakry; Safaa S Soliman
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2018-04-20

9.  Neuroprotective effects of Hu-Yi-Neng, a diet supplement, on SH-SY5Y human neuroblastoma cells.

Authors:  Y-H Yang; T-J Hsieh; M-L Tsai; C-H Chen; H-T Lin; S-J Wu
Journal:  J Nutr Health Aging       Date:  2014       Impact factor: 4.075

10.  Apparent mtDNA sequence heterogeneity in single human blood CD34+ cells is markedly affected by storage and transport.

Authors:  Yong-Gang Yao; Sachiko Kajigaya; Leigh Samsel; J Philip McCoy; Giuseppe Torelli; Neal S Young
Journal:  Mutat Res       Date:  2013-09-14       Impact factor: 2.433

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.